Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia

    ... evaluation should be considered in upfront intensive chemotherapy -ineligible patients. ...

    Research Article last updated 11/02/2016 - 9:17am.

  2. Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

    ... trial studies the feasibility of having induction chemotherapy in an outpatient setting. Patients with acute leukemia (AML) ... will be examined. Treating eligible patients with induction chemotherapy in an outpatient setting may save in healthcare cost and improve a ...

    Clinical Trial last updated 04/27/2016 - 9:49am.

  3. Nurses’ Live Surprise for Robin Roberts

    ... feeling of isolation she experienced while going through chemotherapy , telling the story that she shared on Harry. "Before my ... I had to have my immune system completely wiped out with chemotherapy," she wrote. "I went into the hospital thinking that I was going ...

    Article last updated 10/31/2016 - 7:24am.

  4. A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients with Myelodysplastic Syndrome (MDS)

    ... Treatment with other investigational agents including chemotherapy , immunotherapy, or radiation therapy within a month prior to ... Day 1 or who has not recovered (i.e., Has had prior chemotherapy, targeted small molecule therapy, or radiation therapy within 2 ...

    Clinical Trial last updated 05/14/2018 - 1:57pm.

  5. Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter?

    ... with pretransplant therapy such as intensive induction chemotherapy or hypomethylating agent treatment. Randomized data are ...

    Research Article last updated 04/29/2016 - 10:22am.

  6. Transplant saves student who thought she had mono

    ... I spent eight days getting three different types of chemotherapy to incapacitate my immune system so it wouldn’t reject my ...

    Article last updated 03/06/2017 - 2:37pm.

  7. A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination with Azacitidine for the Treatment of TP53 Mutant Myeloid Neoplasms

    ... intrauterine device or double barrier method during chemotherapy treatment and for at least six months thereafter. ...

    Clinical Trial last updated 04/21/2018 - 6:04pm.

  8. Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

    ... may follow these transplants because of the high-dose chemotherapy and radiation that accompany the procedure. Also, donated ... and skin. To reduce toxicity of high-dose preparative chemotherapy, this study performs allogeneic transplant after low doses of ...

    Clinical Trial last updated 04/28/2016 - 11:28am.

  9. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... study b.         Eligible to receive induction chemotherapy , such as 7-10 days of cytosine arabinoside and 2-3 days of an ... Any other concurrent investigational agent or chemotherapy, radiotherapy, or immunotherapy, or corticosteroids ( ...

    Clinical Trial last updated 05/04/2018 - 3:53pm.

  10. Builds supportive community to help him with MDS and bone marrow transplant

    ... The first eight days of Duane’s treatment consisted of chemotherapy sessions to destroy his own bone marrow . During this ...

    Patient Chronicle last updated 04/26/2018 - 10:50am.